| Primary |
| Thermal Burn |
19.4% |
| Anaesthesia |
16.1% |
| Product Used For Unknown Indication |
16.1% |
| Pyoderma Gangrenosum |
12.9% |
| Pneumonia |
6.5% |
| Wound |
6.5% |
| Wound Treatment |
6.5% |
| Analgesic Effect |
3.2% |
| Burn |
3.2% |
| Depression |
3.2% |
| Pemphigus Vulgaris |
3.2% |
| Radiotherapy |
3.2% |
|
| Product Quality Issue |
10.5% |
| Renal Failure Acute |
10.5% |
| Application Site Erosion |
5.3% |
| Blister |
5.3% |
| Dermatitis Contact |
5.3% |
| Hypersensitivity |
5.3% |
| Methaemoglobinaemia |
5.3% |
| Pain In Extremity |
5.3% |
| Parosmia |
5.3% |
| Pseudomembranous Colitis |
5.3% |
| Rash |
5.3% |
| Rash Erythematous |
5.3% |
| Skin Discolouration |
5.3% |
| Swollen Tongue |
5.3% |
| Vomiting |
5.3% |
| White Blood Cell Count Decreased |
5.3% |
| Wound Drainage |
5.3% |
|
| Secondary |
| Product Used For Unknown Indication |
28.0% |
| Maternal Exposure Timing Unspecified |
12.8% |
| Cardiac Failure |
8.8% |
| Drug Use For Unknown Indication |
6.4% |
| Hypertension |
5.6% |
| Cardiac Disorder |
4.8% |
| Pharyngitis |
4.8% |
| Muscle Spasticity |
4.0% |
| Stevens-johnson Syndrome |
3.2% |
| Blood Cholesterol Increased |
2.4% |
| Constipation |
2.4% |
| Gastrooesophageal Reflux Disease |
2.4% |
| Infection |
2.4% |
| Pain |
2.4% |
| Thermal Burn |
2.4% |
| Agitation |
1.6% |
| Evidence Based Treatment |
1.6% |
| Rash |
1.6% |
| Sleep Disorder |
1.6% |
| Depression |
0.8% |
|
| Toxic Epidermal Necrolysis |
28.6% |
| Pain |
14.3% |
| Thrombosis |
14.3% |
| Circumstance Or Information Capable Of Leading To Medication Error |
4.8% |
| Condition Aggravated |
4.8% |
| Drug Hypersensitivity |
4.8% |
| Premature Baby |
4.8% |
| Rhabdomyolysis |
4.8% |
| Stevens-johnson Syndrome |
4.8% |
| Thermal Burn |
4.8% |
| Urticaria |
4.8% |
| Varicose Ulceration |
4.8% |
|
| Concomitant |
| Product Used For Unknown Indication |
34.4% |
| Drug Use For Unknown Indication |
18.2% |
| Pain |
8.3% |
| Breast Cancer Metastatic |
3.9% |
| Breast Cancer |
3.6% |
| Hypercalcaemia |
3.2% |
| Non-small Cell Lung Cancer |
2.9% |
| Hypertension |
2.7% |
| Asthma |
2.5% |
| Rash |
2.4% |
| Rhinitis Allergic |
2.1% |
| Diarrhoea |
2.0% |
| Pancreatic Insufficiency |
2.0% |
| Rheumatoid Arthritis |
2.0% |
| Diabetes Mellitus |
1.8% |
| Infection |
1.8% |
| Atrial Fibrillation |
1.5% |
| Depression |
1.5% |
| Fibromyalgia |
1.5% |
| Hypersensitivity |
1.5% |
|
| Wound Infection Staphylococcal |
16.5% |
| Weight Increased |
8.2% |
| Hypophosphataemia |
7.1% |
| Toxicity To Various Agents |
7.1% |
| Weight Decreased |
7.1% |
| Thrombocytopenia |
5.9% |
| Wound Infection |
5.9% |
| Death |
4.7% |
| Pulmonary Embolism |
4.7% |
| Gerstmann's Syndrome |
3.5% |
| Pain |
3.5% |
| Rash |
3.5% |
| Skin Ulcer |
3.5% |
| Wheezing |
3.5% |
| Wound |
3.5% |
| Cardiac Failure Congestive |
2.4% |
| Depression |
2.4% |
| Headache |
2.4% |
| Incontinence |
2.4% |
| Intentional Overdose |
2.4% |
|
